Guía para infecciones de transmisión sexual, Bibliografía

Guía para infecciones de transmisión sexual, Bibliografía
Nota: Para mayor información de las referencia bibliográficas y evidencia asociada a las recomendaciones, favor remitirse a la versión completa de esta guía.

1. Ángel-Müller E, González MP, Núñez L., Pacheco J, Tolosa J E., Díaz LA, et al. Frecuencia de infecciones del tracto genital femenino en mujeres sintomáticas y uso de pruebas rápidas para su diagnóstico en dos poblaciones de Bogotá (Colombia) 2008: Estudio piloto. Rev Colomb Obstet Ginecol 2010;61(3):220- 30.
2. Workowski KA, Berman S. Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2010;59(RR 12):1-110.
3. UnAIDS/WHO. Sexually transmitted diseases: policies and principles for prevention and care. . UnAIDS Best Practice Collection Key Material Geneva: UnAIDS/ WHO. 1999.
4. OMS. Guías para el tratamiento de las infecciones de transmisión sexual. Organización Mundial de la Salud; 2005.
5. WHO. World Health Organization. Sexually transmitted infections. Fact sheet August 2011.
6. Johnson L, Bradshaw D, Dorrington R. South African Comparative Risk Assessment Collaborating Group. The burden of disease attributable to sexually transmitted infections in South Africa in 2000. S Afr Med J. 2007;97(8):658-62.
7. Acosta J P, Rodriguez D, C. R. Situacion de las enfermedades de transmision sexual, Colombia,1976-2000. Biomédica. 2002;22(1):77- 88.
8. Munoz N. Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol. 2000 Oct;19(1-2):1-5.
9. Trei JS, Canas LC, Gould PL. Reproductive tract complications associated with Chlamydia trachomatis infection in US Air Force males within 4 years of testing. Sex Transm Dis. 2008 Sep;35(9):827-33.
10. Pultorak E, Wong W, Rabins C, Mehta SD. Economic burden of sexually transmitted infections: incidence and direct medical cost of Chlamydia, gonorrhea, and syphilis among Illinois adolescents and young adults, 2005- 2006. Sex Transm Dis. 2009 Oct;36(10):629-36.
11. Ministerio_de_Salud, Republica_de_Colombia. Guía de Atención de Enfermedades de Transmisión Sexual. Resolución Número 412 De 2000. . . 2000.
12. Lewis DA, Lukehart SA. Antimicrobial resistance in Neisseria gonorrhoeae and Treponema pallidum: evolution, therapeutic challenges and the need to strengthen global surveillance. Sex Transm Infect. 2011;87(2): 39-44.
13. RCOG. Management of acute pelvic inflammatory disease – Green Top Guideline No.32. Royal College of Obstetricians and Gynaecologist. 2008.
14. PHAC. Canadian Guidelines on Sexually Transmitted Infections. Public Health Agency of Canada.; 2010.
15. Ng BE, Butler LM, Horvath T, Rutherford GW. Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection. Cochrane Database Syst Rev. 2011(3):CD001220.
16. NIAID. Workshop summary: scientific evidence on condom effectiveness for sexually transmitted disease (STD) prevention. 2001(Available at www. niaid.nih.gov/about/organization/dmid/documents/condomre¬port.pdf.).
17. Wilkinson D, Ramjee G, Tholandi M, Rutherford G. Nonoxynol-9 for preventing vaginal acquisition of sexually transmitted infections by women from men. Cochrane Database Syst Rev. 2002(4):CD003939.
18. Padian NS, Buve A, Balkus J, Serwadda D, Cates W, Jr. Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward. Lancet. 2008 Aug 16;372(9638):585-99.
19. IUSTI-WHO. European STD guidelines Int J STD AIDS. Suppl 3:2-3; 2001. p. 1-94.
20. Trelle S, Shang A, Nartey L, Cassell JA, Low N. Improved effectiveness of partner notification for patients with sexually transmitted infections: systematic review. BMJ. 2007 Feb 17;334(7589):354.
21. Chin HB, Sipe TA, Elder R, Mercer SL, Chattopadhyay SK, Jacob V, et al. The effectiveness of group-based comprehensive risk-reduction and abstinence education interventions to prevent or reduce the risk of adolescent pregnancy, human immunodeficiency virus, and sexually transmitted infections: two systematic reviews for the Guide to Community Preventive Services. Am J Prev Med. 2012 Mar;42(3):272-94.
22. Nuñez L, Moyano L, Gaitán H, Tolosa J, Ángel E, et_al. Exactitud de las pruebas rápidas para C. trachomatis, N. gonorrhoeae y sífilis a ser aplicadas en el punto de cuidado en mujeres con signos de infección del tracto genital inferior en Bogotá, Colombia 2010. Convocatoria 493 de Colciencias. Artículo en preparación.
23. Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis. 2002 Sep;29(9):497-502.
24. Sendag F, Terek C, Tuncay G, Ozkinay E, Guven M. Single dose oral azithromycin versus seven day doxycycline in the treatment of non-gonococcal mucopurulent endocervicitis. Aust N Z J Obstet Gynaecol. 2000 Feb;40(1):44-7.
25. Guven MA, Gunyeli I, Dogan M, Ciragil P, Bakaris S, Gul M. The demographic and behavioural profile of women with cervicitis infected with Chlamydia trachomatis, Mycoplasma hominis and Ureaplasma urealyticum and the comparison of two medical regimens. Arch Gynecol Obstet. 2005 Sep;272(3):197-200.
26. Rustomjee R, Kharsany AB, Connolly CA, Karim SS. A randomized controlled trial of azithromycin versus doxycycline/ciprofloxacin for the syndromic management of sexually transmitted infections in a resource-poor setting. J Antimicrob Chemother. 2002 May;49(5):875-8.
27. Bai Z, Bao X, WD WC, KH KY, Li Y. Efficacy and safety of ceftriaxone for uncomplicated gonorrhoea: a meta-analysis of randomized controlled trials. . Int J STD AIDS. 2012;23(2):126-32.
28. Shams ur R, Khan A, Amanullah, Akhter K. Clinical efficacy of the various drugs used in the treatment of gonorrhoeae. J Ayub Med Coll Abbottabad. 2009 Oct-Dec;21(4):28-30.
29. Crosby Ra, DiClemente RJ, Wingood GM, Salazar LF, Rose E, Levine D, et al. Associations Between Sexually Transmitted Disease Diagnosis and Subsequent Sexual Risk and Sexually Transmitted Disease Incidence Among Adolescents. Sexually Transmitted Diseases. 2004;31(4):205-8.
30. Schillinger JA, Kissinger P, Calvet H, Whittington WL, Ransom RL, Sternberg MR, et al. Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: a randomized, controlled trial. Sex Transm Dis. 2003 Jan;30(1):49- 56.
31. Golden MR, Whittington WL, Handsfield HH, Hughes JP, Stamm WE, Hogben M, et al. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med. 2005 Feb 17;352(7):676-85.
32. Brocklehurst P, Rooney G. Interventions for treating genital chlamydia trachomatis infection in pregnancy. Cochrane Database Syst Rev. 2000(2):CD000054.
33. Pitsouni E, Iavazzo C, Athanasiou S, Falagas ME. Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta-analysis of randomised controlled trials. Int J Antimicrob Agents. 2007 Sep;30(3):213-21.
34. Turrentine MA, Newton ER. Amoxicillin or erythromycin for the treatment of antenatal chlamydial infection: a meta-analysis. Obstet Gynecol. 1995 Dec;86(6):1021-5.
35. Brocklehurst P. Antibiotics for gonorrhoea in pregnancy. Cochrane Database Syst Rev. 2002(2):CD000098.
36. Cavenee MR, Farris JR, Spalding TR, Barnes DL, Castaneda YS, Wendel GD. Treatment of gonorrhea in pregnancy. Obstet Gynecol. 1993 Jan;81(1):33-8.
37. McDonald HM, Brocklehurst P, Gordon A. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev. 2007(1):CD000262.
38. Takahashi S, Ichihara K, Hashimoto J, Kurimura Y, Iwasawa A, Hayashi K, et al. Clinical efficacy of levofloxacin 500 mg once daily for 7 days for patients with non-gonococcal urethritis. J Infect Chemother. 2011;17(3):392-6.
39. Schwebke J, Rompalo A, Taylor S, Seña A, Martin D, Lopez L, et al. Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens–a randomized clinical trial. Clin Infect Dis. 2012;52(2):163-70.
40. Rolfs RT, Joesoef MR, Hendershot EF, Rompalo AM, Augenbraun MH, Chiu M, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N Engl J Med. 1997 Jul 31;337(5):307-14.
41. Bai Z, Wang B, Yang K, Tian J, Ma B, Liu Y, et al. Azithromycin versus penicillin G benzathine for early syphilis. CochraneDatabase of Systematic Reviews 2012(6):CD007270.
42. Bai ZG, Yang KH, Liu YL, Tian JH, Ma B, Mi DH, et al. Azithromycin vs. benzathine penicillin G for early syphilis: a meta-analysis of randomized clinical trials. Int J STD AIDS. 2008 Apr;19(4):217-21.
43. Tucker JD, Bu J, Brown LB, Yin YP, Chen XS, Cohen MS. Accelerating worldwide syphilis screening through rapid testing: a systematic review. Lancet Infect Dis. 2010 Jun;10(6):381-6.
44. Moorthy TT, Lee CT, Lim KB, Tan T. Ceftriaxone for treatment of primary syphilis in men: a preliminary study. Sex Transm Dis. 1987 Apr- Jun;14(2):116-8.

Anterior Siguiente

DÉJANOS TU COMENTARIO

DÉJANOS TU COMENTARIO

Please enter your comment!